Lilly Direct dispenses FDA-approved Zepbound the same finished tirzepatide product that ran the SURMOUNT trials, manufactured by Eli Lilly under the FDA's regulatory framework for finished drug products
YW: Formal analysis, Resources, Supervision, Writing review & editing
Weight loss during menopause is physiologically harder due to declining estrogen and progesterone, which reduces metabolic rate and increases insulin resistance
Brain Research, 1641 (Pt B), 207-216
Alternatives and Personalized Approaches to GLP-1 Therapy If depression or mood instability emerges during semaglutide treatment, options include dose reduction, switching to a different GLP-1 medication with different pharmacokinetics, or temporarily pausing therapy while addressing the underlying mood disorder with psychiatric support
doi: 10.1186/1471-2407-6-26 81 PolosukhinVVCatesJMLawsonWEMilstoneAPMatafonovAGMassionPPet al